Vanda Pharmaceuticals (VNDA) Prepares to Explore Sale - Reuters

September 22, 2016 3:44 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

(Updated - September 22, 2016 3:46 PM EDT)

Vanda Pharmaceuticals (NASDAQ: VNDA) is preparing to consider strategic alternatives including a potential sale, according to Reuters, citing people familiar. The company is said to be holding conversations with investment banks about naming a financial adviser to help it review options.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment